Petter Nielsen
Plus aucun poste en cours
Provenance du réseau au premier degré de Petter Nielsen
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 10 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Petter Nielsen via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
VERNALIS | Pharmaceuticals: Major | Corporate Officer/Principal | |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Piper Sandler Ltd.
Piper Sandler Ltd. Investment Banks/BrokersFinance Part of Piper Sandler Cos., Piper Sandler Ltd. is a brokerage services provider. The company is based in London, UK. The British company was founded in 1999. Neil Robert Mackison has been the CEO of the company since 2006. | Investment Banks/Brokers | Chief Executive Officer | |
Brown University | College/University | Masters Business Admin | |
NorgesInvestor Formuesforvaltning AS
NorgesInvestor Formuesforvaltning AS Investment ManagersFinance NorgesInvestor Formuesforvaltning AS is a group of companies that focuses on strategic and financial value development. The private company's investment arm, NorgesInvestor Proto, invests in companies listed on the Oslo Stock Exchange. The company is based in Oslo, Norway. and has subsidiaries in Norway and Sweden. The Norwegian company was founded in 1996 by Jan Gunnar Hartvig, Stein Holst Annexstad. The CEO is Øivind E. Hermansen. | Investment Managers | Founder | |
ING Barings Group LLC
ING Barings Group LLC Investment Banks/BrokersFinance Part of ING Groep NV, ING Barings Group LLC is a British company that provides investment banking and financial services. The company is based in London, UK. | Investment Banks/Brokers | Corporate Officer/Principal | |
University of Oxford | College/University | Doctorate Degree | |
Oxford Brookes University | College/University | Masters Business Admin | |
OPTOS PLC | Medical Specialties | Director/Board Member | |
ONCOPEPTIDES AB | Pharmaceuticals: Major | Director/Board Member | |
Cancer Research Technology Ltd.
Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Corporate Officer/Principal | |
University of Oslo | College/University | Graduate Degree Graduate Degree | |
Ruprecht-Karls-Universität Heidelberg | College/University | Graduate Degree | |
University of Bergen | College/University | Corporate Officer/Principal Doctorate Degree | |
Ernst & Young AS
Ernst & Young AS Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young AS is a Norwegian company that provides accounting services. The company is based in Oslo, Norway. The CEO of the company is Christin Erichsen Bøsterud. | Miscellaneous Commercial Services | Director/Board Member | |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
LYTIX BIOPHARMA | Pharmaceuticals: Major | Director/Board Member | |
Investinor AS
Investinor AS Investment ManagersFinance Investinor AS is a Venture Capital firm, a subsidiary of Innovasjon Norge founded in 2008. The company is headquartered in Trondheim. | Investment Managers | Chairman | |
REMA 1000 AS
REMA 1000 AS Food RetailRetail Trade REMA 1000 AS retails grocery products and offers a chain of supermarket. Its office tasks include joint marketing and procurement, finance and information technology, operations, establishing, and central support. The regional offices provides regional marketing and establishes new stores in the area. The company was founded in 1979 and is headquartered in Oslo, Norway. | Food Retail | Director of Finance/CFO | |
Helse Bergen HF Haukeland Universitetssjukehus
Helse Bergen HF Haukeland Universitetssjukehus Medical/Nursing ServicesHealth Services Helse Bergen HF Haukeland Universitetssjukehus is a healthcare company based in Bergen, Norway. Haukeland universitetssjukehus has over 14,000 skilled employees who work every day to provide patients with high-quality specialist health services when they need them. The Norwegian company is ultimately controlled by the Government of Norway. The company was founded in 2001, and the CEO is Eivind Hansen. | Medical/Nursing Services | Corporate Officer/Principal | |
Warszawski Uniwersytet Medyczny | College/University | Doctorate Degree | |
Akershus Universitetssykehus HF
Akershus Universitetssykehus HF Hospital/Nursing ManagementHealth Services Akershus Universitetssykehus HF operates as local and regional hospital. Its main tasks are patient treatment, research, teaching, and patient education. The firm offers somatic, mental health care, and drug treatment. The company was founded on December 5, 2001 and is headquartered in Lorenskog, Norway. | Hospital/Nursing Management | Chairman | |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Pharmaceuticals: Major | Director/Board Member | |
SPAGO NANOMEDICAL AB | Biotechnology | Director/Board Member | |
University of Kent | College/University | Undergraduate Degree | |
Oslo universitetssykehus HF
Oslo universitetssykehus HF Hospital/Nursing ManagementHealth Services Oslo universitetssykehus HF operates local hospital, acute hospitals, and regional hospital for residents and has a number of national tasks. It carries out patient treatment, research, and trial treatments, gives advice and provides education. The company was founded on December 1, 2008 and is headquartered in Oslo, Norway. | Hospital/Nursing Management | Chairman | |
ULTIMOVACS ASA | Pharmaceuticals: Major | Director/Board Member | |
Pharmacia & Upjohn Co. LLC
Pharmacia & Upjohn Co. LLC Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pharmacia & Upjohn Co. LLC is a company that manufactures and supplies pharmaceutical goods. The company is based in Bingham Farms, MI. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
WG Partners LLP
WG Partners LLP Investment Banks/BrokersFinance WG Partners LLP is a specialist life sciences boutique that provides corporate advisory, M&A, and capital raising services. The private company is based in London, UK, with an additional office in Sydney, Australia. The British company has completed transactions with a total value in excess of £8.2 billion and is 100% owned by the partners who combine more than 250 years of relevant experience. The company brings a truly international perspective, acting for corporate and institutional clients across Europe, the USA, and Australia. The company was founded in 2011 by David Ian Wilson. | Investment Banks/Brokers | Founder | |
HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Director/Board Member | |
COMBIGENE AB | Pharmaceuticals: Major | Director/Board Member | |
Blueprint Genetics Oy
Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. | Biotechnology | Chairman | |
SEDANA MEDICAL AB | Medical Specialties | Director/Board Member | |
Bergen Hospital Trust | Chief Executive Officer | ||
Norwegian Pharmaceutical Society | Chairman | ||
Norgesinvest AS | Founder | ||
NorgesInvestor Value AS
NorgesInvestor Value AS Financial ConglomeratesFinance NorgesInvestor Value AS operates as asset management group that focuses on creating strategic and financial values for institutional and private clients. Its business includes wealth management, investments in listed securities, and private equity secondaries. The company was founded by Stein Holst Annexstad, Jan Gunnar Hartvig, and Trond Erik Wennberg in 1996 and is headquartered in Oslo, Norway. | Financial Conglomerates | Founder | |
Pluvia AS
Pluvia AS Miscellaneous Commercial ServicesCommercial Services Pluvia AS operates as a research-based pharmaceutical company. The company is headquartered in Bergen, Norway. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
SOFTOX SOLUTIONS | Miscellaneous Commercial Services | Director/Board Member | |
Bio-Me AS
Bio-Me AS BiotechnologyHealth Technology Bio-Me AS operates as a boi-tech firm. It researches and develops patented technologies and new approaches in bacteria analysis. The company is headquartered in Oslo, Norway. | Biotechnology | Director/Board Member | |
K & K AS
K & K AS Miscellaneous Commercial ServicesCommercial Services K & K AS manages securities. The company was founded on June 26, 2002 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Chief Executive Officer | |
Tappin AS | Director/Board Member | ||
Norwegian Cancer Society | Director/Board Member | ||
ONCOZENGE AB | Pharmaceuticals: Major | Director/Board Member | |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | Biotechnology | Director/Board Member |
Statistiques
Internationale
Norvège | 26 |
Royaume-Uni | 14 |
Suède | 6 |
Etats-Unis | 4 |
Finlande | 3 |
Sectorielle
Health Technology | 22 |
Consumer Services | 9 |
Finance | 8 |
Commercial Services | 6 |
Health Services | 4 |
Opérationnelle
Director/Board Member | 38 |
Corporate Officer/Principal | 19 |
Chairman | 14 |
Independent Dir/Board Member | 13 |
Chief Executive Officer | 5 |
Relations les plus connectées
Insiders | |
---|---|
Hilde Furberg | 21 |
Stein Holst Annexstad | 15 |
David Wilson | 14 |
Kari Grønås | 12 |
Anthony Brown | 10 |
Stener Kvinnsland | 9 |
Julia Schölermann | 4 |
Rune Skeie | 4 |
Grzegorz Rychlik | 2 |
Viki Wills | 1 |
- Bourse
- Insiders
- Petter Nielsen
- Connexions Sociétés